Ken Tajima
Impact in
- Cancer Research top 10%
- Cancer, Hypoxia, and Metabolism
- Cancer-related molecular mechanisms research
- Oncology top 10%
- Cancer Cells and Metastasis
Papers in
-
- Lung Cancer Treatments and Mutations 9
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 7
- Occupational and environmental lung diseases 4
- Medical Imaging and Pathology Studies 3
- Oncology 14
- Lung Cancer Research Studies 4
- Co-authors
- Kazuhisa Takahashi (30 shared papers)Fumiyuki Takahashi (23 shared papers)Shyamala Maheswaran (5 shared papers)Shin‐ichiro Iwakami (8 shared papers)Fariz Nurwidya (6 shared papers)Muneaki Hashimoto (5 shared papers)Takeshi Nara (5 shared papers)Naoko Shimada (8 shared papers)
- Journals
- BMC Cancer (2 papers)Nature Communications (2 papers)Lung Cancer (2 papers)Oncogene (2 papers)Biochemical and Biophysical Research Communications (1 paper)
- Partner nations
- JapanUnited StatesCanada
In The Last Decade
Ken Tajima
38 papers receiving 916 citations
Peers
Comparison fields: 5 of 95
- Cancer Research 240
- Oncology 328
- Pulmonary and Respiratory Medicine 295
- Molecular Biology 498
- Biotechnology 38
Countries citing papers authored by Ken Tajima
This map shows the geographic impact of Ken Tajima's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ken Tajima with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ken Tajima more than expected).
Fields of papers citing papers by Ken Tajima
This network shows the impact of papers produced by Ken Tajima. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ken Tajima. The network helps show where Ken Tajima may publish in the future.
Co-authors
The 25 scholars most cited alongside Ken Tajima, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 38 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 105 | |
| 2 | 2011 | 81 | |
| 3 | 2013 | 78 | |
| 4 | 2012 | 57 | |
| 5 | 2011 | 50 | |
| 6 | 2009 | 44 | |
| 7 | 2016 | 44 | |
| 8 | 2010 | 41 | |
| 9 | 2019 | 41 | |
| 10 | 2015 | 40 | |
| 11 | 2019 | 39 | |
| 12 | 2008 | 38 | |
| 13 | 2013 | 29 | |
| 14 | 2018 | 20 | |
| 15 | 2022 | 20 | |
| 16 | 2020 | 20 | |
| 17 | Distinct roles of cholinergic receptors in small cell lung cancer cells. | 2010 | 18 |
| 18 | Osteopontin modulates malignant pleural mesothelioma cell functions in vitro. | 2009 | 16 |
| 19 | 2001 | 15 | |
| 20 | 2009 | 13 |
About Ken Tajima
Ken Tajima is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Molecular Biology, Rheumatology and Epidemiology, having authored 38 papers that have together received 927 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (9 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (7 papers), Bone and Dental Protein Studies (5 papers), Epigenetics and DNA Methylation (4 papers), Lung Cancer Research Studies (4 papers), Neuroendocrine Tumor Research Advances (4 papers), Occupational and environmental lung diseases (4 papers) and Medical Imaging and Pathology Studies (3 papers). The work is most often cited by research in Cancer Research (240 citations), Oncology (328 citations), Pulmonary and Respiratory Medicine (295 citations), Molecular Biology (498 citations) and Biotechnology (38 citations). Ken Tajima has collaborated with scholars based in Japan, United States and Canada. Frequent co-authors include Kazuhisa Takahashi, Fumiyuki Takahashi, Shyamala Maheswaran, Shin‐ichiro Iwakami, Fariz Nurwidya, Muneaki Hashimoto, Takeshi Nara, Naoko Shimada, Hiroyuki Moriyama and Isao Kobayashi. Their work appears in journals such as BMC Cancer, Nature Communications, Lung Cancer, Oncogene and Biochemical and Biophysical Research Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.